CopyFind
Ketomar Ophthalmic Solution
medicine 📍 IN

Ketomar Ophthalmic Solution

201,16 ₹

Analogs of Ketomar Ophthalmic Solution

Find cheaper analogs and generic equivalents for Ketomar Ophthalmic Solution.

Ingredients

Principio activo: Gatifloxacin (0.3% w/v); Ketorolac (0.4% w/v)


Resumen del producto

About Ketomar Ophthalmic Solution

Ketomar Ophthalmic Solution is a medication containing the active ingredient Gatifloxacin. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family that, like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV.

Key Benefits & Uses

  • Used for: 1 INDICATIONS & USAGE Gatifloxacin ophthalmic solution 0
  • Used for: 5 % is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic gram-positive.
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Gatifloxacin, the active ingredient in Ketomar Ophthalmic Solution, is the pharmacologically active substance of this product. 1 INDICATIONS & USAGE Gatifloxacin ophthalmic solution 0. 5 % is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic gram-positive bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus mitis group* Streptococcus oralis* Streptococ…. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Ketomar Ophthalmic Solution. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Ketomar Ophthalmic Solution for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Ketomar Ophthalmic Solution.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.